Assistant Professor of Surgery, David Geffen School of Medicine at UCLA
General Surgery
Dr. Fady M. Kaldas, MD
|
|
Give Review
Fady Kaldas is an expert in the field of General Surgery. He attended University of California Irvine School of Medicine. University of California Irvine School of Medicine has a rank of 45 in research and a 62 in primary care He received 1 awards: "Fellow (FACS)". Doctor Fady M. Kaldas, MD is also published. He has 29 publications published. The lastest publication: "Reduction of hepatic ischemia/reperfusion injury by a soluble P-selectin glycoprotein ligand-1.' He is registered with Medicare.
Publications
- Incidence and risk factors for deep venous thrombosis and pulmonary embolus after Liver transplantation.
- Damage Control as a Strategy to Manage Postreperfusion Hemodynamic Instability and Coagulopathy in Liver Transplant.
- Complete pathologic response to pretransplant locoregional therapy for hepatocellular carcinoma defines cancer cure after Liver transplantation: analysis of 501 consec...
- A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after Liver transplantation: analysis of 865 consecutive Liver transplant recipients.
- Reoperative complications after primary orthotopic Liver transplantation: a contemporary single-center experience in the post-model for end-stage Liver disease era.
- Liver transplantation in recipients receiving renal replacement therapy: outcomes analysis and the role of intraoperative hemodialysis.
- Liver Transplantation in Highest Acuity Recipients: Identifying Factors to Avoid Futility.
- Liver Transplantation in Children Using Organ Donation After Circulatory Death: A Case-Control Outcomes Analysis of a 20-Year Experience in a Single Center.
- Liver transplantation for lethal genetic syndromes: a novel model of personalized genomic medicine.
- Blood Transfusion Requirement During Liver Transplantation is an Important Risk Factor for Mortality.
- Assessment of hepatic steatosis by transplant surgeon and expert pathologist a prospective, double-blind evaluation of 201 donor Livers.
- Management of recurrent hepatocellular carcinoma in Liver transplant recipients: a systematic review.
- Twenty-four years after Liver transplantation, the recipient becomes a body donor.
- Liver transplantation using organ donation after cardiac death: a clinical predictive index for graft failure-free survival.
- Predictive Index for Long-Term Survival After Retransplantation of the Liver in Adult Recipients: Analysis of a 26-Year Experience in a Single Center.
- Interleukin-13 protects mouse intestine from ischemia and reperfusion injury through regulation of innate and adaptive immunity.
- Predictive index for tumor recurrence after Liver transplantation for locally advanced intrahepatic and hilar cholangiocarcinoma.
- Feasibility and safety of percutaneous coronary intervention in patients with end-stage Liver disease referred for Liver transplantation.
- Liver transplantation for hepatocellular carcinoma: an update.
- Tezosentan, a novel endothelin receptor antagonist, markedly reduces rat hepatic ischemia and reperfusion injury in three different models.
- Renal function impacts outcomes after Intestinal transplantation.
- Cytoprotective gene bi-1 is required for intrinsic protection from endoplasmic reticulum stress and ischemia-reperfusion injury.
- Vascular endothelial growth factor antagonist modulates leukocyte trafficking and protects mouse Livers against ischemia/reperfusion injury.
- P-selectin glycoprotein ligand-1 (rPSGL-Ig)-mediated blockade of CD62 selectin molecules protects rat steatotic Liver grafts from ischemia/reperfusion injury.
- Reduction of hepatic ischemia/reperfusion injury by a soluble P-selectin glycoprotein ligand-1.
- Effects of pravastatin on chronic rejection of rat cardiac allografts.
- Renal event outcomes in Intestinal transplantation: results from a single-center experience.
- FK330, a novel inducible nitric oxide synthase inhibitor, prevents ischemia and reperfusion injury in rat Liver transplantation.
Schools
University of California At Irvine California College of Medicine amp Surgery
Procedures Preformed
- Biliary Drainage
- Cholecystoenterostomy
- Colectomy
- Embolectomy, Thrombectomy, or Vessel Exploration
- View All
Conditions Treated
- Abdominal Pain
- Atelectasis
- Biliary Atresia
- Cholecystitis and Gallstones
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- Fellow (FACS)
Education
-
SUNY Stony Brook University Hospital & Medical Center -
University of California Irvine School of Medicine
Hospital
-
Ronald Reagan UCLA Medical Center
Drug Facts
| NPI NUMBER | 1700050598 | |
| NPPES Provider LastName | KALDAS | |
| NPPES Provider FirstName | FADY | |
| NPPES Provider ZIPCode | 900247002 | |
| NPPES Provider State | CA | |
| Specialty Description | General Surgery | |
| Total Claim Count | 34.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1700050598 |
| Last Name Of The Provider | KALDAS |
| First Name Of The Provider | FADY |
| View All |
Similar Doctors
|
|
Dr. Keira L. Kamm, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kenneth W. Adashek, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Theodore X. O'Connell III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Emmanuel A. Ayodele, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hassan A. Khalil, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Constance M. Mobley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew Scott, MD |